Genmab A/S - GMAB

SEC FilingsOur GMAB Tweets

About Gravity Analytica

Recent News

  • 12.31.2025 - Financial Calendar Year End
  • 11.06.2025 - Publication of the Interim Report for the First Nine Months 2025 (after 5:00 PM CET)
  • 09.10.2025 - Genmab A/S has published its Articles of Association
  • 09.10.2025 - Genmab A/S has published its Articles of Association
  • 09.09.2025 - Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons
  • 09.09.2025 - Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons
  • 09.09.2025 - Capital Increase in Genmab as a Result of Employee Warrant Exercise
  • 09.09.2025 - Capital Increase in Genmab as a Result of Employee Warrant Exercise
  • 09.09.2025 - Morgan Stanley 23rd Annual Global Healthcare Conference
  • 09.03.2025 - Genmab Announces Updated Results from Phase 2 EPCORE® NHL-6 Study Evaluating Epcoritamab Monotherapy in the Outpatient Setting in Patients with Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL)

Recent Filings

  • 09.10.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
  • 09.09.2025 - EX-99.1 EX-99.1
  • 09.09.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]